Mark Prygocki
Director/Board Member bij VERRICA PHARMACEUTICALS INC.
Vermogen: - $ op 31-03-2024
Profiel
Mark A.
Prygocki is currently the Director at Visions of Hope, Inc., an Independent Director at Verrica Pharmaceuticals, Inc., and a Member of both The Financial Executives Institute and the New York State Society of Certified Public Accountants.
Previously, he served as the President, Chief Executive Officer & Director at Illustris Pharmaceuticals, Inc. from 2017 to 2020, an Independent Director at Revance Therapeutics, Inc. from 2014 to 2017, a Director at The Whispering Hope Ranch Foundation, an Independent Director at Clarus Therapeutics Holdings, Inc. from 2021 to 2022, and the Executive Director at Clarus Therapeutics, Inc. from 2014 to 2022.
Prior to that, he was the President at Medicis Pharmaceutical Corp.
from 2010 to 2012 and a Principal at Ernst & Young LLP.
He obtained his undergraduate degree from Pace University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
08-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Mark Prygocki
Bedrijven | Functie | Begin |
---|---|---|
VERRICA PHARMACEUTICALS INC. | Director/Board Member | 01-05-2018 |
The Financial Executives Institute | Corporate Officer/Principal | - |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Corporate Officer/Principal | 14-04-2010 |
Eerdere bekende functies van Mark Prygocki
Bedrijven | Functie | Einde |
---|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Director/Board Member | 01-12-2022 |
CLARUS THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 31-10-2022 |
REVANCE THERAPEUTICS, INC. | Director/Board Member | 11-05-2017 |
MEDICIS PHARMACEUTICAL CORP | President | 11-12-2012 |
Opleiding van Mark Prygocki
Pace University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
VERRICA PHARMACEUTICALS INC. | Health Technology |
CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
The Financial Executives Institute | |
New York State Society of Certified Public Accountants
New York State Society of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services New York State Society of Certified Public Accountants is a non-profit organization. It provides a membership program for certified public accountants that offers in-person and online networking opportunities, Continuing Professional Education courses and conferences, the CPA Journal, and other publications. The company was foudned in 1897 and is headquartered in New York, NY. | Commercial Services |
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |